SCHEMBL7268568

SCHEMBL7268568

COc1cc2nc(-c3ccc(Cl)cc3)nc(NCC(=O)O)c2cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.55
KMT2A Q03164 6/20 0.47
MEN1 O00255 5/20 0.47
HTT P42858 2/20 0.47
TP53 P04637 2/20 0.47
MAPT P10636 1/20 0.47
RXFP1 Q9HBX9 1/20 0.46
TSHR P16473 3/20 0.46
WHR1 P49842 1/20 0.45
TLR9 Q9NR96 1/20 0.45
MAPK1 P28482 1/20 0.45
EGFR P00533 2/20 0.44
KDR P35968 2/20 0.44
KDM1A O60341 1/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
HSD17B10 Q99714 2/20 0.44
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7262033 0.91 KMT2A (0.54) PDE10AKMT2AMEN1HTTTP53
SCHEMBL7267747 0.90 PDE10A (0.65) PDE10AKMT2AMEN1HTTTP53
SCHEMBL7262660 0.84 HTT (0.68) KMT2AMEN1HTTTP53MAPT
SCHEMBL7262687 0.82 MEN1 (0.65) KMT2AMEN1HTTTP53MAPT
SCHEMBL7267768 0.82 MEN1 (0.60) KMT2AMEN1HTTTP53MAPT
SCHEMBL7262644 0.80 MEN1 (0.71) KMT2AMEN1HTTTP53MAPT
SCHEMBL7261431 0.80 HTT (0.56) KMT2AMEN1HTTTP53MAPT
Hydrochloric Acid SCHEMBL7266371 0.79 POLB (0.47) KMT2AMEN1HTTTP53MAPT
Acetic Acid SCHEMBL7268584 0.77 WHR1 (0.49) KMT2AMEN1HTTTP53MAPT
SCHEMBL7268476 0.76 MEN1 (0.60) KMT2AMEN1HTTTP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613772-B1 Drugs such as 2-(p-chlorophenyl-4-(4-hydroxybutyl)amino-6,7,8 -trimethoxyquinazoline used for activation of guanylate cyclase and modulation of cyclic guanosine monophosphate AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-02 US disclosed